[go: up one dir, main page]

WO2013114363A3 - Agents antimicrobiens - Google Patents

Agents antimicrobiens Download PDF

Info

Publication number
WO2013114363A3
WO2013114363A3 PCT/IL2013/050083 IL2013050083W WO2013114363A3 WO 2013114363 A3 WO2013114363 A3 WO 2013114363A3 IL 2013050083 W IL2013050083 W IL 2013050083W WO 2013114363 A3 WO2013114363 A3 WO 2013114363A3
Authority
WO
WIPO (PCT)
Prior art keywords
antimicrobial agents
seq
nos
carrier
amino acid
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/IL2013/050083
Other languages
English (en)
Other versions
WO2013114363A2 (fr
WO2013114363A8 (fr
Inventor
Rotem Sorek
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Yeda Research and Development Co Ltd
Original Assignee
Yeda Research and Development Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Yeda Research and Development Co Ltd filed Critical Yeda Research and Development Co Ltd
Publication of WO2013114363A2 publication Critical patent/WO2013114363A2/fr
Publication of WO2013114363A8 publication Critical patent/WO2013114363A8/fr
Publication of WO2013114363A3 publication Critical patent/WO2013114363A3/fr
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/315—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Streptococcus (G), e.g. Enterococci

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)

Abstract

La présente invention concerne des compositions antimicrobiennes, comprenant un véhicule et en tant que substance active un polypeptide isolé comprenant une séquence d'acides aminés choisie dans le groupe constitué de SEQ ID NO: 1-113.
PCT/IL2013/050083 2012-01-30 2013-01-30 Agents antimicrobiens Ceased WO2013114363A2 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201261592026P 2012-01-30 2012-01-30
US61/592,026 2012-01-30

Publications (3)

Publication Number Publication Date
WO2013114363A2 WO2013114363A2 (fr) 2013-08-08
WO2013114363A8 WO2013114363A8 (fr) 2013-10-10
WO2013114363A3 true WO2013114363A3 (fr) 2013-11-28

Family

ID=47844414

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/IL2013/050083 Ceased WO2013114363A2 (fr) 2012-01-30 2013-01-30 Agents antimicrobiens

Country Status (1)

Country Link
WO (1) WO2013114363A2 (fr)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB201322396D0 (en) 2013-12-18 2014-02-05 Univ Nottingham Transduction

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2002034771A2 (fr) * 2000-10-27 2002-05-02 Chiron Srl Acides nucleiques et proteines derives des groupes de streptocoques a et b

Family Cites Families (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL154600B (nl) 1971-02-10 1977-09-15 Organon Nv Werkwijze voor het aantonen en bepalen van specifiek bindende eiwitten en hun corresponderende bindbare stoffen.
NL154598B (nl) 1970-11-10 1977-09-15 Organon Nv Werkwijze voor het aantonen en bepalen van laagmoleculire verbindingen en van eiwitten die deze verbindingen specifiek kunnen binden, alsmede testverpakking.
NL154599B (nl) 1970-12-28 1977-09-15 Organon Nv Werkwijze voor het aantonen en bepalen van specifiek bindende eiwitten en hun corresponderende bindbare stoffen, alsmede testverpakking.
US3901654A (en) 1971-06-21 1975-08-26 Biological Developments Receptor assays of biologically active compounds employing biologically specific receptors
US3853987A (en) 1971-09-01 1974-12-10 W Dreyer Immunological reagent and radioimmuno assay
US3867517A (en) 1971-12-21 1975-02-18 Abbott Lab Direct radioimmunoassay for antigens and their antibodies
NL171930C (nl) 1972-05-11 1983-06-01 Akzo Nv Werkwijze voor het aantonen en bepalen van haptenen, alsmede testverpakkingen.
US3850578A (en) 1973-03-12 1974-11-26 H Mcconnell Process for assaying for biologically active molecules
US3935074A (en) 1973-12-17 1976-01-27 Syva Company Antibody steric hindrance immunoassay with two antibodies
US3996345A (en) 1974-08-12 1976-12-07 Syva Company Fluorescence quenching with immunological pairs in immunoassays
US4034074A (en) 1974-09-19 1977-07-05 The Board Of Trustees Of Leland Stanford Junior University Universal reagent 2-site immunoradiometric assay using labelled anti (IgG)
US3984533A (en) 1975-11-13 1976-10-05 General Electric Company Electrophoretic method of detecting antigen-antibody reaction
US4098876A (en) 1976-10-26 1978-07-04 Corning Glass Works Reverse sandwich immunoassay
US4879219A (en) 1980-09-19 1989-11-07 General Hospital Corporation Immunoassay utilizing monoclonal high affinity IgM antibodies
US5011771A (en) 1984-04-12 1991-04-30 The General Hospital Corporation Multiepitopic immunometric assay
US4666828A (en) 1984-08-15 1987-05-19 The General Hospital Corporation Test for Huntington's disease
US4683202A (en) 1985-03-28 1987-07-28 Cetus Corporation Process for amplifying nucleic acid sequences
US4801531A (en) 1985-04-17 1989-01-31 Biotechnology Research Partners, Ltd. Apo AI/CIII genomic polymorphisms predictive of atherosclerosis
JP2874751B2 (ja) 1986-04-09 1999-03-24 ジェンザイム・コーポレーション 希望する蛋白質をミルク中へ分泌する遺伝子移植動物
US4873316A (en) 1987-06-23 1989-10-10 Biogen, Inc. Isolation of exogenous recombinant proteins from the milk of transgenic mammals
US5272057A (en) 1988-10-14 1993-12-21 Georgetown University Method of detecting a predisposition to cancer by the use of restriction fragment length polymorphism of the gene for human poly (ADP-ribose) polymerase
US5302523A (en) 1989-06-21 1994-04-12 Zeneca Limited Transformation of plant cells
US5464764A (en) 1989-08-22 1995-11-07 University Of Utah Research Foundation Positive-negative selection methods and vectors
US5192659A (en) 1989-08-25 1993-03-09 Genetype Ag Intron sequence analysis method for detection of adjacent and remote locus alleles as haplotypes
US5281521A (en) 1992-07-20 1994-01-25 The Trustees Of The University Of Pennsylvania Modified avidin-biotin technique
US5541110A (en) 1994-05-17 1996-07-30 Bristol-Myers Squibb Cloning and expression of a gene encoding bryodin 1 from Bryonia dioica
US8513489B2 (en) 2006-12-15 2013-08-20 The Regents Of The University Of California Uses of antimicrobial genes from microbial genome

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2002034771A2 (fr) * 2000-10-27 2002-05-02 Chiron Srl Acides nucleiques et proteines derives des groupes de streptocoques a et b

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
DATABASE Geneseq [online] 2 July 2002 (2002-07-02), "Streptococcus polypeptide SEQ ID NO 9366.", XP002696678, retrieved from EBI accession no. GSP:ABP30095 Database accession no. ABP30095 *
DATABASE UniProt [Online] 25 November 2008 (2008-11-25), "SubName: Full=Putative uncharacterized protein;", XP002696677, retrieved from EBI accession no. UNIPROT:B6C6N7 Database accession no. B6C6N7 *

Also Published As

Publication number Publication date
WO2013114363A2 (fr) 2013-08-08
WO2013114363A8 (fr) 2013-10-10

Similar Documents

Publication Publication Date Title
WO2014205317A3 (fr) Peptides cycliques utilisés en tant qu'agents de ciblage de protéines
EP4230644A3 (fr) Peptide pénétrant dans les cellules, conjugué le comprenant, et composition comprenant le conjugué
WO2013102144A8 (fr) Variants du polypeptide ph20, formulations en contenant et leurs utilisations
MX2020010399A (es) 3-epimerasa.
WO2012087288A3 (fr) Compositions de sels métalliques
UA118167C2 (uk) Пептид та його застосування
WO2013000922A9 (fr) Peptides antagonistes de ccr2
EA201201263A1 (ru) Фармацевтическая композиция, содержащая этексилат дабигатрана
WO2012048176A3 (fr) Formulations d'attachement et de rétention pour composés organiques biologiquement actifs
HK1200314A1 (en) R(+)-n-methyl-propargyl-aminoindan
EP3266317A4 (fr) Composition pour prévenir, améliorer ou traiter des troubles neurologiques, contenant un peptide d'osmotine comme principe actif
WO2011145872A3 (fr) Composition pour la prévention de la perte de cheveux ou la stimulation de la pousse des cheveux
WO2011122872A3 (fr) Composition comprenant du coumestrol ou un extrait de fèves contenant du coumestrol
EP4653537A3 (fr) Rhodopsin-gentherapie zur regeneration des sehvermögens oder zur verhinderung der abnahme des sehvermögens
WO2011094504A3 (fr) Compositions, procédés et dispositifs d'irrigation de sinus antimicrobienne
WO2012087051A3 (fr) Microparticules contenant un peptide physiologiquement actif, procédé pour les préparer et composition pharmaceutique les contenant
AU2011365688A8 (en) Peptides with antimicrobial activity, drug compositions for the prophylaxis and treatment of animals, compositions for the prophylaxis and treatment of plants, uses of said peptides, and uses of Paenibacillus elgii ourofinensis extract
WO2011067209A3 (fr) Mélanges pesticides
WO2012148720A3 (fr) Peptides antimicrobiennes et leurs procédés d'utilisation
WO2012061360A3 (fr) Compositions pharmaceutiques
WO2014106798A3 (fr) Peptides anti-microbiens, compositions les comprenant et utilisations
WO2013114363A3 (fr) Agents antimicrobiens
HK1215571A1 (zh) 二盐酸科比思特
WO2013092208A3 (fr) Suspension d'antitranspirant à vaporiser, à libération de principe actif améliorée et réduisant les salissures sur les textiles
PL2699254T3 (pl) Sposób proteolizy, zastosowanie kompozycji jako środka bakteriostatycznego lub bakteriobójczego oraz zastosowania aktywnej formy LytM z S. aureus

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 13708530

Country of ref document: EP

Kind code of ref document: A2

WWE Wipo information: entry into national phase

Ref document number: 233904

Country of ref document: IL

122 Ep: pct application non-entry in european phase

Ref document number: 13708530

Country of ref document: EP

Kind code of ref document: A2